Edwards Lifesciences (EW) PT Lowered to $128 at Oppenheimer, Keeps 'OP' Rating
Tweet Send to a Friend
Oppenheimer analyst Suraj Kalia lowered the price target on Edwards Lifesciences (NYSE: EW) to $128.00 (from $135.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
